Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid

Molecular Neurobiology

Volumn 53, Issue 5, 2016, Pages 3205-3215

  Hachem, Mayssa ^a   Géloën, Alain ^a   Van, Amanda Lo ^a   Foumaux, Baptiste ^a   Fenart, Laurence ^b   Gosselet, Fabien ^b   Da Silva, Pedro ^a   Breton, Gildas ^c   Lagarde, Michel ^a   Picq, Madeleine ^a   Bernoud Hubac, Nathalie ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ D'ARTOIS   (France)

^c Polaris   (France)

Author keywords

Blood brain barrier; Brain; Docosahexaenoic acid; Lyso phosphatidylcholine; Transport

Indexed keywords

1 ACETYL,2 DOCOSAHEXAENOYL GLYCEROPHOSPHOCHOLINE C 14; 1 PALMITOYL,2 DOCOSAHEXAENOYL GLYCEROPHOSPHOCHOLINE C 14; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID C 14; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN REGION; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; ESTERIFICATION; GLIA CELL; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; LIPID ANALYSIS; LIPOPHILICITY; MOLECULAR MODEL; NEWBORN; NONHUMAN; RADIOACTIVITY; RAT; STATIC ELECTRICITY; SYNTHESIS; ANIMAL; AUTORADIOGRAPHY; BIOLOGICAL MODEL; BRAIN; CHEMISTRY; ENDOTHELIUM CELL; METABOLISM; TIME FACTOR; TISSUE DISTRIBUTION;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BLOOD-BRAIN BARRIER; BRAIN; DOCOSAHEXAENOIC ACIDS; ENDOTHELIAL CELLS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PHOSPHATIDYLCHOLINES; RADIOACTIVITY; RATS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84930353492     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9228-9     Document Type: Article

References (42)

1. Saravanan P, Davidson N, Schmidt E, Calder P (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376:540–550
2. Mozaffarian D, Wu J (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58:2047–2067
3. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z et al (2013) Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38:1154–1163
4. O’Brien J, Sampson E (1965) Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 6:545–551
5. Bourre JM, Bonneil M, Clément M, Dumont O, Durand G, Lafont H, Nalbone G, Piciotti M (1993) Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukot Essent Fatty Acids 48:5–15
6. Jensen M, Skarsfeldt T, Hoy C (1996) Correlation between level of (n-3) polyunsaturated fatty acids in brain phospholipids and learning ability in rats. A multiple generation study. Biochim Biophys Acta 1300:203–209
7. Makrides M, Neumann M, Gibson R (1996) Is dietary docosahexaenoic acid essential for term infants? Lipids 31:115–119
8. Rogers L, Valentine C, Keim S (2013) DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 70:13–19
9. Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease. FASEB J 22:1213–1225
10. Hashimoto M, Hossain S (2011) Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer’s disease. J Pharmacol Sci 116:150–162
11. Dacks P, Shineman D, Fillit H (2013) Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging 17:240–251
12. Bazinet RP, Layé S (2014) Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15(12):771–785
13. Thies F, Pillon C, Moliere P, Lagarde M, Lecerf J (1994) Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol 267:R1273–R1279
14. Bernoud N, Fenart L, Molière P, Dehouck MP, Lagarde M, Cecchelli R, Lecerf J (1999) Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem 72:338–345
15. Croset M, Brossard N, Polette A, Lagarde M (2000) Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 345(Pt 1):61–67
16. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL et al (2014) Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509:503–506
17. Polette A, Deshayes C, Chantegrel B, Croset M, Armstrong JM, Lagarde M (1999) Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids 34:1333–1337
18. Lagarde M, Hachem M, Bernoud-Hubac N, Picq M, Vericel E, Guichardant M (2015) Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain. Prostaglandins Leukot Essent Fatty Acids 92:63--65
19. Lagarde M, Guichardant M, Picq M, Michaud S, Doutheau S (2008) Method for preparing acetyl, docosahexaenoyl-glycerophosphocholine and use thereof for delivering polyunsaturated fatty acids WO/2008/068413
20. Chauveau F, Cho TH, Perez M, Guichardant M, Riou A, Aguettaz P, Picq M, Lagarde M et al (2011) Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact. Curr Neurovasc Res 8:95–102
21. Virto C, Adlercreutz P (2000) Lysophosphatidylcholine synthesis with Candida antarctica lipase B (Novozym 435). Enzyme Microb Technol 26:630–635
22. Booher J, Sensenbrenner M (1972) Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 2:97–105
23. Descamps L, Coisne C, Dehouck B, Cecchelli R, Torpier G (2003) Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury. Glia 42:46–58
24. Bornstein MB (1958) Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. Lab Invest 7:134–137
25. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
26. Folch J, Lees M, Sloane Stanley G (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509
27. Picq M, Chen P, Perez M, Michaud S, Véricel E, Guichardant M, Lagarde M (2010) DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol 42:48–51
28. Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V et al (2008) An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro 22:799–811
29. Hallier-Vanuxeem D, Prieto P, Culot M, Diallo H, Landry C, Tahti H, Cecchelli R (2009) New strategy for alerting central nervous system toxicity: integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment. Toxicol In Vitro 23:447–453
30. Sovic A, Panzenboeck U, Wintersperger A, Kratzer I, Hammer A, Levak-Frank S, Frank S, Rader DJ et al (2005) Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier. J Neurochem 94:109–119
31. Chen S, Subbaiah P (2007) Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochim Biophys Acta 1771:1319–1328
32. Bernoud N, Fenart L, Bénistant C, Pageaux JF, Dehouck MP, Moliere P, Lagarde M, Cecchelli R et al (1998) Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro. J Lipid Res 39:1816–1824
33. LaDu MJ, Gilligan SM, Lukens JR, Cabana VG, Reardon CA, Van Eldik LJ, Holtzman DM (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 70:2070–2081
34. Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS (2000) Lipoproteins in the central nervous system. Ann N Y Acad Sci 903:167–175
35. Xiao Y, Huang Y, Chen Z (2005) Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain. Br J Nutr 94:544–55036
36. Diau GY, Hsieh AT, Sarkadi-Nagy EA, Wijendran V, Nathanielsz PW, Brenna JT (2005) The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med 3:11
37. Thies F, Delachambre M, Bentejac M, Lagarde M, Lecerf J (1992) Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem 59:1110–1116
38. Leaf A, Kang J, Xiao Y, Billman G, Voskuyl R (1999) Functional and electrophysiologic effects of polyunsaturated fatty acids on excitable tissues: heart and brain. Prostaglandins Leukot Essent Fatty Acids 60:307–312
39. Weylandt K, Kang J, Leaf A (1996) Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids. Lipids 31:977–982
40. Anderson G, Connor W (1988) Uptake of fatty acids by the developing rat brain. Lipids 23:286–290
41. Onuma Y, Masuzawa Y, Ishima Y, Waku K (1984) Selective incorporation of docosahexaenoic acid in rat brain. Biochim Biophys Acta 793:80–85
42. Sarda N, Gharib A, Moliere P, Grange E, Bobillier P, Lagarde M (1991) Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat. Neurosci Lett 123:57–60